Aakash Desai to Disease-Free Survival
This is a "connection" page, showing publications Aakash Desai has written about Disease-Free Survival.
Connection Strength
0.029
-
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma. Oncologist. 2017 05; 22(5):549-553.
Score: 0.029